Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DRUGSBUGS

Financiado

Improved therapies for soil transmitted helminthiases exploring pharmacomicrobi...

Improved therapies for soil transmitted helminthiases exploring pharmacomicrobiomics novel drugs and microfluidic assay platforms An estimated 1.5 billion people are infected with soil-transmitted helminths (STHs) causing a global burden of 1.9 million disability-adjusted life years (DALYs). Current treatment options are limited. Preliminary studies in my la... ver más

31/12/2026

SWISS TPH SWISS TR...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INST... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-07-14

ERC-2020-ADG: ERC ADVANCED GRANT

I+D

Cerrada hace 4 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

SWISS TPH SWISS TROPICAL AND...

2.47M€ | Lider

LIVERCO

203.50K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2020-119035RB-I00 NUEVAS HERRAMIENTAS PARA EL DESCUBRIMIENTO DE FARMACOS Y LA... 212K€ Cerrado

DEFEAT DiseasE FreE social life without Antibiotics resisTance 2M€ Cerrado

AGL2008-03187 FASCIOLOSIS: ESTUDIO DE LA QUIMIORESISTENCIA Y SU RELACION G... 48K€ Cerrado

PID2020-118405RB-I00 REDUCCION DE LA RESISTENCIA A LOS ANTIMICROBIANOS EN ENTEROB... 200K€ Cerrado

PID2021-123184OA-I00 DECIFRANDO LOS MICOBIOMAS DE HOSPITALES QUE ESTAN ASOCIADOS... 206K€ Cerrado

GutTransForm Gut microbiota drug biotransformation as a tool to unravel t... 2M€ Cerrado

Duración del proyecto: 65 meses Fecha Inicio: 2021-07-14
Fecha Fin: 2026-12-31

Líder del proyecto

SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INST... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Descripción del proyecto An estimated 1.5 billion people are infected with soil-transmitted helminths (STHs) causing a global burden of 1.9 million disability-adjusted life years (DALYs). Current treatment options are limited. Preliminary studies in my lab hint towards a gut microbiome mechanism responsible for treatment failures of the most efficacious treatment currently available, albendazole-ivermectin. I propose an innovative 5-year project (DRUGSBUGS) that holds promise for major breakthroughs in anthelminthic drug discovery and development. I will deepen the understanding of current and potentially upcoming anthelminthics, in particular the microbiome-driven modulation of anthelminthic treatment. I will investigate underlying gut microbial structures in human stool samples associated with efficacy of albendazole-ivermectin treatment. Findings will be experimentally validated in vitro and in vivo. In addition, I speculate that emodepside will emerge as a novel key player in the anthelminthic drug armamentarium, which will enhance efficacy and reduce the risk of selection of resistant helminth populations. DRUGSBUGS proposes two Phase 2a dose selection trials with emodepside against Trichuris trichiura and hookworm in adults. Subsequent Phase 2b studies will assess whether emodepside is superior to albendazole against hookworm and T. trichiura. Using a microsampling technique, I will characterize the pharmacokinetics of emodepside in patients infected with T. trichiura and hookworm. In parallel, investing in innovative new technologies in the field of drug discovery will facilitate the discovery and development of the next generation of anthelminthics. I propose to study drug effects on motility and viability of different STH larvae applying electrical impedance spectroscopy on a microfluidic chip platform. My proposed research is of considerable public health relevance since it will ultimately result in improved treatments for soil-transmitted helminthiases.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores